FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States.
52W Range
7thpctl
Volume
0.67×avg
Market Cap
3.02MUSD
P/E Ratio
-0.2TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
FibroBiologics, Inc. Common Stock
FBLGNASDAQ Capital Market·USD·Closed
FibroBiologics, Inc. Common Stock
FBLGNASDAQ·USD·Closed
$1.44
−3.36%
$1.44
−$0.05 (3.36%)
52W Range
7thpctl
Volume
0.67×avg
Mkt Cap
3.02MUSD
P/E
-0.2TTM
Div Yield
–ann
FBLG: FibroBiologics, Inc. Common Stock Stock Analysis | finqOS
